These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 20020554)

  • 1. Coronary artery disease and the use of stents.
    Am Fam Physician; 2009 Dec; 80(11):1252-3. PubMed ID: 20020554
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug-eluting coronary artery stents.
    Dehmer GJ; Smith KJ
    Am Fam Physician; 2009 Dec; 80(11):1245-51. PubMed ID: 19961137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease.
    Mehilli J; Kastrati A; Byrne RA; Bruskina O; Iijima R; Schulz S; Pache J; Seyfarth M; Massberg S; Laugwitz KL; Dirschinger J; Schömig A;
    J Am Coll Cardiol; 2009 May; 53(19):1760-8. PubMed ID: 19422982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-eluting stent for long coronary artery disease.
    Park SJ; Kim YH
    Indian Heart J; 2008; 60(6):519-23. PubMed ID: 19276489
    [No Abstract]   [Full Text] [Related]  

  • 5. Antiplatelet therapy in the era of drug-eluting stents: current and future perspectives.
    Ducrocq G; Serebruany V; Tanguay JF
    Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):939-53. PubMed ID: 17867923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-eluting stents for saphenous vein graft lesions: the limits of evidence.
    Bittl JA
    J Am Coll Cardiol; 2009 Mar; 53(11):929-30. PubMed ID: 19281921
    [No Abstract]   [Full Text] [Related]  

  • 8. Status of drug-eluting coronary stents.
    Chodosh A; Korr KS; Burtt D
    Med Health R I; 2008 Oct; 91(10):309-12, 314. PubMed ID: 19044106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous stenting of the left main with drug eluting stents for in-stent restenosis: immediate- and long-term results.
    Mixon T; Fitzsimmons P
    J Invasive Cardiol; 2006 Jun; 18(6):E166-8. PubMed ID: 16775892
    [No Abstract]   [Full Text] [Related]  

  • 10. Applying drug-eluting stents in clinical practice.
    King SB
    Am J Cardiol; 2007 Sep; 100(5A):25K-31K. PubMed ID: 17719350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The problem of stent thrombosis associated with drug-eluting stents and the optimal duration of dual antiplatelet therapy.
    Ayyanathan S; Hersh D; Coplan NL; Garratt K
    Prev Cardiol; 2009; 12(2):59-64. PubMed ID: 19476578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The editor's roundtable: bare-metal stents versus drug-eluting stents-indications and complications.
    Friedewald VE; Kastrati A; Roberts WC; Vetrovec GW; Windecker S
    Am J Cardiol; 2008 Jul; 102(1):32-9. PubMed ID: 18572032
    [No Abstract]   [Full Text] [Related]  

  • 13. [Drug-eluting stents in multivessel coronary artery disease: Was one of the important fortresses of surgery conquered?].
    Okmen AS; Okmen E
    Anadolu Kardiyol Derg; 2009 Aug; 9(4):325-30. PubMed ID: 19666436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degradable, drug-eluting stents: a new frontier for the treatment of coronary artery disease.
    Kohn J; Zeltinger J
    Expert Rev Med Devices; 2005 Nov; 2(6):667-71. PubMed ID: 16293093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous treatment of a coronary aneurysm by stent graft and drug-eluting stent implantation: a potential method to reduce stent graft restenosis.
    Süselbeck T; Haghi D; Borggrefe M; Kaden JJ
    J Interv Cardiol; 2008 Aug; 21(4):325-8. PubMed ID: 18754968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes after multilesion percutaneous coronary intervention: comparison between exclusive and selective use of drug-eluting stents.
    Bertrand OF; Faurie B; Larose E; Nguyen CM; Gleeton O; Déry JP; Noël B; Proulx G; Roy L; Costerousse O; De Larochellière R; Rodés-Cabau J
    J Invasive Cardiol; 2008 Mar; 20(3):99-104. PubMed ID: 18316823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are drug-eluting stents safe?: Definitely! Or probably... possibly? Or maybe not yet...
    Nakazawa G; Ladich E; Virmani R
    Clin Pharmacol Ther; 2009 Aug; 86(2):127-30. PubMed ID: 19621005
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug-eluting stents for the treatment of coronary artery disease: NICE technology appraisal guidance.
    Messori A; Trippoli S
    Heart; 2009 May; 95(10):847. PubMed ID: 19401286
    [No Abstract]   [Full Text] [Related]  

  • 19. The high cost of nonadherence after percutaneous coronary intervention--can health care reform solve this problem?
    Mukherjee D
    Am Heart J; 2009 Oct; 158(4):506-8. PubMed ID: 19781406
    [No Abstract]   [Full Text] [Related]  

  • 20. Diabetic multivessel disease: stenting vs. coronary artery bypass grafting.
    Bansilal S; Farkouh M; Sharma S; Fuster V
    Indian Heart J; 2007; 59(2 Suppl B):B72-82. PubMed ID: 19153439
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.